EMMAUS LIFE SCIENCES, INC.
Income Statement
| Line Item | FY2017 |
|---|---|
| Revenue | $128.5K |
| Cost of Revenue | $53.5K |
| Gross Profit | $75.0K |
| Gross Margin | 58.4% |
| Operating Expenses | |
| Research & Development | — |
| SG&A Expense | $4.6M |
| Operating Income | $-7.1M |
| Operating Margin | -5,528.1% |
| Interest Expense | — |
| Pretax Income | $-7.1M |
| Income Tax Expense | $2.6K |
| Net Income | $-7.1M |
| Net Margin | -5,535.3% |
| EPS (Basic) | $-2.52 |
| EPS (Diluted) | $-2.52 |
| Shares Outstanding (Basic) | 4.4M |
| Shares Outstanding (Diluted) | 4.4M |
| Dividends Per Share | — |